Amarin Corp. (AMRN) option implied volatility elevated into sharp rally on release of patient study

Amarin Corp. (NASDAQ: AMRN) September weekly call option implied volatility is at 566, October is at 300; compared to its 52-week range of 35 to 428 into the release of an 8,000 patient study started in 2011 for their omega3 pill Vascepa.

You May Also Be Interested In

• Micron Technology (MU) call put ratio 1.2 calls to 1 put into quarter results
• Infleqtion (INFQ) call put ratio 19 calls to 1 put with a focus on July 30 and August 20 calls as share price up 13.2%
• Qualcomm (QCOM) June 26 weekly 200 and 230 calls active into investor meeting